Summary: CVS Corp. - S&P Global Ratings’ Credit Research

Summary: CVS Corp.

Summary: CVS Corp. - S&P Global Ratings’ Credit Research
Summary: CVS Corp.
Published Mar 11, 2004
Published Mar 11, 2004
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

The ratings on CVS Corp. (CVS) reflect the company's solid position in the favorably regarded drugstore industry and the belief that management is committed to maintaining a moderate financial policy. CVS, with more than 4,100 units, is the second-largest chain drug retailer in the U.S. based on sales and store count. Prescriptions, which constitute about 69% of the company's revenues, continue to drive growth and are expected to do well prospectively based on an aging population, greater use of pharmaceuticals in outpatient therapy, and the ongoing development of new drug products. The company has historically generated consistent operating performance, but had difficulty in the second half of 2001 through the first half of 2002 due to a shortage of pharmacists

  
Report Type:

Summary

Ticker
Issuer
GICS
Health Care Services (35102015)
Sector
Global Issuers , Structured Finance
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

Research Update: CVS Corp. – 2004/04/05 – US$ 225.00

Research Update: CVS Corp. – 2004/04/29 – US$ 225.00

Summary: CVS Corp. – 2004/06/25 – US$ 225.00

Summary: CVS Corp. – 2004/02/17 – US$ 225.00

CVS Corp. – 2003/11/25 – US$ 500.00

Summary: CVS Corp. – 2003/11/25 – US$ 225.00

Summary: CVS Corp. – 2003/09/22 – US$ 225.00

Summary: CVS Corp. – 2003/06/30 – US$ 225.00

More from S&P Global Ratings’ Credit Research

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Summary: CVS Corp." Mar 11, 2004. Alacra Store. May 11, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Summary-CVS-Corp-363553>
  
APA:
S&P Global Ratings’ Credit Research. (). Summary: CVS Corp. Mar 11, 2004. New York, NY: Alacra Store. Retrieved May 11, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Summary-CVS-Corp-363553>
  
US$ 225.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Residential Mortgage-Backed Securities from one place.